Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Luca Richeldi, Roland M. du Bois, Ganesh Raghu et al. · New England Journal of Medicine · 2014 · 4.4K citations · Full text

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu, Martine Rémy‐Jardin, Jeffrey L. Myers et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 3.9K citations

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.8K citations · Full text

A Common <i>MUC5B</i> Promoter Polymorphism and Pulmonary Fibrosis

Max A. Seibold, Anastasia L. Wise, Marcy C. Speer et al. · New England Journal of Medicine · 2011 · 1.2K citations · Full text

Muc5b is required for airway defence

Michelle G. Roy, Alessandra Livraghi-Butrico, Ashley A. Fletcher et al. · Nature · 2013 · 751 citations · Full text

Lung Inflammation, Pulmonary Medicine, Airway Defence +2